Thalidomide and low-dose dexamethasone in myeloma treatment [4]

British Journal of Haematology

Volumn 114, Issue 1, 2001, Pages 245-

  Myers, B ^a   Grimley, C ^a   Dolan, G ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Dexamethasone; Myeloma; Thalidomide

Indexed keywords

CYTOKINE; DEXAMETHASONE; IMMUNOGLOBULIN LIGHT CHAIN; INTERLEUKIN 6; PARAPROTEIN; THALIDOMIDE;

CLINICAL ARTICLE; DRUG POTENTIATION; DRUG RESPONSE; HUMAN; LETTER; MYELOMA; PRIORITY JOURNAL; RASH;

DEXAMETHASONE; DRUG THERAPY, COMBINATION; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIPLE MYELOMA; THALIDOMIDE;

EID: 0034928810     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Thalidomide treatment in advanced refractory myeloma
2. Thalidomide plus dexamethasone and thalidomide alone as first line therapy for newly diagnosed myeloma
3. Continuous low-dose dexamethasone in relapsed or refractory multiple myeloma